MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Area della Ricerca S. Cataldo, Via Moruzzi, 1, 56124, Pisa, Italy.
Ematologia II con Talassemia, Ospedale "V. Cervello", Palermo, Italy.
Eur Radiol. 2020 Jun;30(6):3217-3225. doi: 10.1007/s00330-020-06668-1. Epub 2020 Feb 12.
R2* cardiac magnetic resonance (CMR) allows the non-invasive measurement of myocardial iron. We calibrated cardiac R2* values against myocardial tissue-measured iron concentration by using a segmental approach and we assessed the iron distribution.
Five hearts of thalassemia patients were donated after death/transplantation to the CoreLab of the Myocardial Iron Overload in Thalassemia Network. A multislice multiecho R2* approach was adopted. After CMR, used as guidance, the heart was cut in three short-axis slices and each slice was cut into different equiangular segments according to AHA segmentation and differentiated into endocardial and epicardial layers. Tissue iron concentration was measured by atomic absorption spectrometer technique.
Fifty-five samples were used since only for two hearts all the 16 samples were analyzed. Mean iron concentration was 4.71 ± 4.67 mg/g dw. Segmental iron levels ranged from 0.24 to 13.78 mg/g dw. The coefficient of variability of iron for myocardial segments ranged from 8.08 to 24.54% (mean 13.49 ± 6.93%). Iron concentration was significantly higher in the epicardial than in the endocardial layer (5.99 ± 6.01 vs 4.84 ± 4.87 mg/g dw; p = 0.042). Four different circumferential regions (anterior, septal, inferior, and lateral) were defined. A circumferential heterogeneity was noted, with more iron in the anterior region, followed by the inferior region. The direct nonlinear fitting of R2* and [Fe] data led to the calibration curve: [Fe] = 0.0022 ∙ (R2*-ROI) (R-square = 0.956).
Our data further validate R2* CMR using a segmental approach as a sensitive and early technique for quantifying iron distribution in the current clinical practice.
• Calibration in humans for cardiovascular magnetic resonance R2* against myocardial iron concentration was provided. • A circumferential heterogeneity in cardiac iron distribution was detected: more iron was observed in the anterior region, followed by the inferior region. This finding corroborates the use of a segmental T2* CMR approach in the clinical practice to detect a heterogeneous iron distribution. • The comparison between the cardiac T2* values obtained with the region-based and the pixel-wise approaches showed a significant correlation and no significant difference but, in presence of significant iron load, the region-based approach resulted in significantly higher T2* values.
心脏磁共振(CMR)R2* 可实现心肌铁的无创测量。我们使用节段法将心脏 R2* 值与心肌组织测量的铁浓度进行校准,并评估铁的分布。
5 例地中海贫血患者死后/移植后将心脏捐赠给地中海贫血网络心肌铁过载核心实验室。采用多层面多回波 R2* 方法。在 CMR 指导下,将心脏切成 3 个短轴切片,并根据 AHA 分段将每个切片切成不同的等角段,分为心内膜和心外膜层。采用原子吸收光谱仪技术测量组织铁浓度。
由于只有 2 颗心脏的 16 个样本全部被分析,因此共使用了 55 个样本。平均铁浓度为 4.71 ± 4.67mg/g dw。节段铁水平范围为 0.24 至 13.78mg/g dw。心肌节段铁的变异系数范围为 8.08%至 24.54%(平均 13.49 ± 6.93%)。心外膜层的铁浓度明显高于心内膜层(5.99 ± 6.01 比 4.84 ± 4.87mg/g dw;p=0.042)。定义了 4 个不同的圆周区域(前、间隔、下和侧)。注意到圆周异质性,前区铁含量较高,其次是下区。R2和[Fe]数据的直接非线性拟合得到校准曲线:[Fe]=0.0022·(R2-ROI)(R 平方=0.956)。
本研究进一步验证了节段法 R2* CMR 作为一种敏感和早期的技术,可在当前临床实践中定量评估铁的分布。
• 为心血管磁共振 R2* 对心肌铁浓度的校准提供了人体数据。
• 心脏铁分布存在圆周异质性:前区铁含量较高,其次是下区。这一发现证实了节段 T2* CMR 方法在临床实践中检测异质铁分布的应用。
• 基于区域和基于像素的 T2* 值比较显示出显著的相关性和无显著差异,但在存在显著铁负荷的情况下,基于区域的方法导致 T2* 值显著升高。